What is a stock summary page? Click here for an overview.
Business Description
InnoCan Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA45783P1027
Share Class Description:
FRA:IP4: Ordinary SharesCompare
Compare
Traded in other countries / regions
INNO.CanadaIP4.GermanyINNPF.USA IPO Date
2020-03-31Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 509.64 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-EBITDA | 0.15 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 8.32 | |||||
| Beneish M-Score | -3.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 431.3 | |||||
| 3-Year EPS without NRI Growth Rate | 21.2 | |||||
| 3-Year FCF Growth Rate | 40.5 | |||||
| 3-Year Book Growth Rate | -19 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.91 | |||||
| 9-Day RSI | 20.62 | |||||
| 14-Day RSI | 31.92 | |||||
| 3-1 Month Momentum % | 0.38 | |||||
| 6-1 Month Momentum % | -4.4 | |||||
| 12-1 Month Momentum % | -39.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.09 | |||||
| Quick Ratio | 2.61 | |||||
| Cash Ratio | 2.24 | |||||
| Days Inventory | 307.51 | |||||
| Days Sales Outstanding | 0.22 | |||||
| Days Payable | 28.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.3 | |||||
| Shareholder Yield % | -2.51 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.9 | |||||
| Operating Margin % | -4.32 | |||||
| Net Margin % | -6.15 | |||||
| FCF Margin % | -5.37 | |||||
| ROE % | -38.8 | |||||
| ROA % | -20.82 | |||||
| ROIC % | 11.29 | |||||
| 3-Year ROIIC % | 913.2 | |||||
| ROC (Joel Greenblatt) % | 5.18 | |||||
| ROCE % | 0.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.07 | |||||
| PB Ratio | 6.18 | |||||
| Price-to-Tangible-Book | 5 | |||||
| EV-to-EBIT | 891.67 | |||||
| EV-to-EBITDA | 441.14 | |||||
| EV-to-Revenue | 1.04 | |||||
| EV-to-FCF | -20.66 | |||||
| Price-to-GF-Value | 0.13 | |||||
| Price-to-Net-Current-Asset-Value | 10 | |||||
| Earnings Yield (Greenblatt) % | 0.11 | |||||
| FCF Yield % | -4.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InnoCan Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 27.185 | ||
| EPS (TTM) (€) | -0.009 | ||
| Beta | 0.39 | ||
| 3-Year Sharpe Ratio | -0.68 | ||
| 3-Year Sortino Ratio | -1.01 | ||
| Volatility % | 50.73 | ||
| 14-Day RSI | 31.92 | ||
| 14-Day ATR (€) | 0.008021 | ||
| 20-Day SMA (€) | 0.12135 | ||
| 12-1 Month Momentum % | -39.86 | ||
| 52-Week Range (€) | 0.0972 - 0.228 | ||
| Shares Outstanding (Mil) | 291.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InnoCan Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InnoCan Pharma Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
InnoCan Pharma Corp Frequently Asked Questions
What is InnoCan Pharma Corp(FRA:IP4)'s stock price today?
The current price of FRA:IP4 is €0.10. The 52 week high of FRA:IP4 is €0.23 and 52 week low is €0.10.
When is next earnings date of InnoCan Pharma Corp(FRA:IP4)?
The next earnings date of InnoCan Pharma Corp(FRA:IP4) is .
Does InnoCan Pharma Corp(FRA:IP4) pay dividends? If so, how much?
InnoCan Pharma Corp(FRA:IP4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers